[1] KURITA T,MATSUURA Y,KOI C,et al. The relationship between positive peritoneal cytology and the prognosis of patients with uterine cervical cancer[J]. Acta Cytol,2015,59(2):201-206.[2] NAINAR S,FENG C,SPITALE R C. Chemical tools for dissecting the role of LncRNAs in epigenetic regulation[J]. ACS Chem Biol,2016,11(8):2091-2100.[3] DENG K,WANG H,GUO X,et al. The cross talk between long,non-coding RNAs and microRNAs in gastric cancer[J]. Acta Biochim Biophys Sin,2016,48(2):111-116.[4] ZHANG Y,WANG T,HUANG H Q,et al. Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis and promotes cell proliferation,invasion and migration[J]. J Buon,2015,20(6):1497-1503.[5] HU Y,SUN X,MAO C,et al. Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration[J]. Cancer Med,2017,6(2):471-482.[6] ZHANG D,SUN G,ZHANG H,et al. Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways[J]. Biomed Pharmacother,2017,85:511-516.[7] ZHANG J,YAO T,WANG Y,et al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21[J]. Cancer Biol Ther,2016,17(1):104-113.[8] LOOIJENGA L H,GILLIS A J,VAN GURP R J,et al. X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status[J]. Am J Pathol,1997,151(2):581-590.[9] FANG J,SUN C C,GONG C. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression[J]. Biochem Biophys Res Commun,2016,478(2):811-817.[10] VARAMBALLY S,CAO Q,MANI R S,et al. Genomic loss of microRNA-101 leads to overexpression of histone methyl-transferase EZH2 in cancer[J]. Science,2008,322 (5908):1695-1699.[11] WANG H J,RUAN H J,HE X J,et al. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion[J]. Eur J Cancer,2010,46(12):2295-2303. |